Innokeys Pte. Ltd Consolidates Nimotuzumab Development by Acquiring Oncoscience AG

Oncoscience | July 22nd, 2015

The acquisition enables Innokeys to fully lead clinical and commercial development of Nimotuzumab in Europe. Transactio...